Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients: Prospective Product Registry

NCT03406091 is registered in ClinicalTrials.gov with Fondazione EMN Italy Onlus as lead sponsor.

NCT NCT03406091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03406091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients: Prospective Product Registry
Lead sponsor
Fondazione EMN Italy Onlus
Phase
Observational
Overall status
Completed
Start date
November 26, 2015
Completion date
January 17, 2024
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma